Metatissue nominated for HIMSS23 – Startup PitchFest

We are excited to announce that Metatissue has been nominated for the HIMSS23 Startup PitchFest, an esteemed event focused on solving healthcare’s validated challenges. Out of numerous contenders, we are honoured to be one of the 11 nominees chosen for this prestigious opportunity.

The HIMSS23 Startup PitchFest serves as a platform for startups, including ours, to showcase their ideas and engage with healthcare insiders, ultimately leading to a more effective process of defining and validating the problems they aim to solve.

Metatissue has been nominated in the categorie of “Most Promising Startups”. This category highlights our potential to make a significant impact in the healthcare sector and our ability to grow and expand our solutions to address critical challenges faced by the industry.

We are thrilled by this nomination and see it as a testament to the dedication and hard work of our team.